LOXL1 Antibody
-
Catalog numberE-AB-16574-120
-
PricePlease ask
-
Size0,12 ml
-
-
ClonalityPolyclonal antibody
-
Full nameLOXL1 Polyclonal Antibody
-
Reacts withhuman mice
-
Tested techniqueELISA WB
-
AntigenSynthetic peptide of human LOXL1
-
Raised inRabbits
-
Purification techniquePurified by affinity chromatography
-
Product solutionPBS with 0.05% sodium azide, 50% glycerol, pH7.3
-
Antibody concentration0.3mg per ml
-
Conjugationwithout a conjugate
-
Suggested work concentrationsWB(1:200-1:1000)
-
Swissprot HQ08397
-
Gene AccessionNP_005567
-
Storage conditionsAccording to the user manual, the product LOXL1 Antibody should be kept at minus twenty degrees Celsius for long-term applications. Collection of small work solutions from the product will help you to avoid multiple procedures of freezing and thawing.
-
TipsThis antibody is intended to be used for research purposes only and it is not manufactured for in vitro diagnostic procedures.
-
PropertiesIf you buy Antibodies supplied by Elabscience they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
-
French translationanticorps
-
Gene target
-
Gene symbolLOXL1-AS1, LOXL1
-
Short nameLOXL1 Antibody
-
TechniqueAntibody, antibodies against human proteins, antibodies for
-
IsotypeImmunoglobulin G
-
Alternative nameLOXL1 (antibody to-)
-
Alternative techniqueantibodies
-
Gene info
-
Identity
-
Gene
-
Long gene nameLOXL1 antisense RNA 1
-
Synonyms gene name
- LOXL1 antisense RNA 1 (non-protein coding)
-
GenBank acession
-
Locus
-
Discovery year2012-06-30
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Antisense RNAs
-
VEGA ID
Gene info
-
Identity
-
Gene
-
Long gene namelysyl oxidase like 1
-
Synonyms gene name
- lysyl oxidase-like 1
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1993-12-08
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
-
Tree numbers
- E05.393.220
-
Qualifiersdrug effects, methods, radiation effects